#	Pagina
attuale pagina	/open-h2020/projects/217442/index.html
-1	/open-h2020/per-topic/arcsar/list/index.html

Opendata, web and dolomites

Sea4Pain SIGNED

Development of a novel analgesic for chronic pain from marine-derived compounds

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

Sea4Pain project word cloud

Explore the words cloud of the Sea4Pain project. It provides you a very rough idea of what is the project "Sea4Pain" about.

worth drug 4 ion pain sensing 13 derivatives raised supporting suffer capital market global applies neurons first chronic opioid platform 2015 breakthroughs channels lab action shows kv professionals modulate cagr constantly 2022 sea4us efficacy patented acting analgesic co channel inflict pharmaceuticals biomedicine pathologies innovative disruptive expand venture switch life quality addiction portuguese series 38 benefits world grants marine modulator received 525 mode pharmaceutical billion drive differentiated moderate alleviate 250 compound drugs derivate limited compounds roll adverse population class sea4pain severe brain habituation 2013 huge give 51 toxicity strategy noxious health team demonstrated biotechnological suffering fifth extremely ease crowdfunding alternative discovery founded patients treatments

Project "Sea4Pain" data sheet

The following table provides information about the project.

Coordinator	SEA4US BIOTECNOLOGIA E RECURSOS MARINHOS LDA Organization address address: RUA DO POENTE S/N city: SAGRES postcode: 8650 378 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Portugal [PT]
Project website	http://sea4us.pt/en/
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
Code Call	H2020-SMEInst-2018-2020-1
Funding Scheme	SME-1
Starting year	2018
Duration (year-month-day)	from 2018-05-01 to 2018-09-30

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	SEA4US BIOTECNOLOGIA E RECURSOS MARINHOS LDA SEA4US BIOTECNOLOGIA E RECURSOS MARINHOS LDA Organization address address: RUA DO POENTE S/N city: SAGRES postcode: 8650 378 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	PT (SAGRES)	coordinator	50˙000.00

Map

Project objective

'The Sea4Pain project will expand and define the development strategy for Sea4Us’s “Drug Discovery and Development Platform” – a platform that applies novel biotechnological approaches to exploit marine derived compounds for the development of novel pharmaceuticals highly relevant for biomedicine. The first lab-based research results have clearly demonstrated the benefits of marine compounds in a series of pathologies, like chronic pain, and the huge potential of its derivate products in the health market. In particular, our innovative breakthroughs will lead to the development of a unique, high efficacy analgesic (ion channel modulator), with reduced toxicity and limited side-effects (Sea4Pain). This extremely innovative approach shows a differentiated mode-of-action (acting directly in the 'pain switch'), that will give rise to a new class of pharmaceutical drugs with no expected adverse effects on the brain (currently being patented). The disruptive compound will modulate specific ion channels in pain-sensing neurons (Kv), for which there is no known modulator, and ease the suffering of one fifth of the World's population who constantly suffer from chronic pain. Sea4Pain will offer alternative treatments for patients suffering from moderate to severe chronic pain. Current drugs in the market (opioid derivatives and others) do alleviate pain but co-inflict important noxious effects (habituation, addiction, loss of drive) and great loss in quality of life. The global pain management drugs and devices market was estimated to be worth $38 billion in 2015 and reach $51 billion in 2022 at a CAGR of 4%. Founded in 2013, Sea4Us has received over 525.000€ in Portuguese and European Research Grants, raised 10.000€ with crowdfunding, and 250.000€ in venture capital, supporting a team of 13 professionals and is focused on developing the Sea4Pain roll-to-market of innovative treatments.'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SEA4PAIN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SEA4PAIN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Woodywood pickering (2019)

Bio-based (fully renewable) cost effective Polymer for new generation of ecological Coatings leveraging a disruptive innovation in the use of Pickering emulsion.